Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial of Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy to Patients With Early Low and Mid Rectal Cancer: The Watchful Waiting 3 Trial (WW3)

NCT04095299 is registered in ClinicalTrials.gov with Vejle Hospital as lead sponsor.

NCT NCT04095299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04095299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial of Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy to Patients With Early Low and Mid Rectal Cancer: The Watchful Waiting 3 Trial (WW3)
Lead sponsor
Vejle Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
January 20, 2020
Completion date
December 31, 2033
Enrollment
162 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of rectum